Does Rallies track congressional trades in HCA?

Yes. Rallies tracks politician and congressional stock disclosures for HCA, including reported purchases, sales, dates, owners, and trade amounts when available.

Is HCA research on Rallies investment advice?

No. Rallies provides research, data, and educational context for HCA. It does not provide personalized investment advice.

HCA (HCA Healthcare, Inc.) Stock Analysis - Politician Trades

HCA Healthcare, Inc. (HCA) is a publicly traded Healthcare sector company. As of May 21, 2026, HCA trades at $390.80 with a market cap of $93.79B and a P/E ratio of 20.74. HCA moved -1.85% today. Year to date, HCA is -16.99%; over the trailing twelve months it is +2.75%. Its 52-week range spans $289.98 to $556.52. Analyst consensus is buy with an average price target of $523.14. Rallies surfaces HCA's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Which politicians traded HCA stock?

Recent politician trading activity in HCA includes disclosures from Ro Khanna, Lisa McClain, Lisa McClain, Julie Johnson, and Rob Bresnahan. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.

HCA Key Metrics

Key financial metrics for HCA
Metric	Value
Price	$390.80
Market Cap	$93.79B
P/E Ratio	20.74
EPS	$19.25
Dividend Yield	0.78%
52-Week High	$556.52
52-Week Low	$289.98
Volume	3.78K
Avg Volume	0
Revenue (TTM)	$64.97B
Net Income	$6.09B
Gross Margin	0.00%

Congressional Trades in HCA

Ro Khanna sale HCA on Oct 27, 2025 (amount: $15.00K).
Lisa McClain sale (full) HCA on Sep 11, 2025 (amount: $15.00K) for Spouse.
Lisa McClain purchase HCA on Aug 19, 2025 (amount: $15.00K) for Spouse.
Julie Johnson sale HCA on Apr 7, 2025 (amount: $15.00K) for Joint.
Rob Bresnahan sale HCA on Feb 25, 2025 (amount: $15.00K).

Latest HCA News

HCA slides as weak Q1 seasonal volumes and new analyst cuts extend selloff — Apr 28, 2026
HCA jumps as 2026 outlook holds; senior-notes refinance plan draws fresh buyers — Apr 27, 2026
HCA drops as Q1 profitability misses expectations on weak seasonal volumes — Apr 26, 2026
HCA sinks after Q1 2026 adjusted EBITDA miss despite reaffirmed full-year guidance — Apr 25, 2026
HCA Healthcare Q1 EPS Hits $7.15 as Cash Flow Jumps 22% Despite Volume Headwinds — Apr 24, 2026

Recent HCA Insider Trades

McAlevey Michael R sold 1.69K (~$903.54K) on Feb 18, 2026.
Wyatt Christopher F. sold 4.00K (~$2.02M) on Feb 11, 2026.
Berres Jennifer sold 4.01K (~$2.02M) on Feb 11, 2026.

HCA Analyst Consensus

14 analysts cover HCA: 0 strong buy, 10 buy, 4 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $523.14.

Common questions about HCA

Which politicians traded HCA stock?: Recent politician trading activity in HCA includes disclosures from Ro Khanna, Lisa McClain, Lisa McClain, Julie Johnson, and Rob Bresnahan. Rallies tracks purchase and sale disclosures, transaction dates, owners, reported amounts, and post-trade performance context.
Does Rallies track congressional trades in HCA?: Yes. Rallies tracks politician and congressional stock disclosures for HCA, including reported purchases, sales, dates, owners, and trade amounts when available.
Is HCA research on Rallies investment advice?: No. Rallies provides research, data, and educational context for HCA. It does not provide personalized investment advice.